Does Health First Colorado Cover Wegovy or Ozempic in 2026? (Updated)

Direct answer – Health First Colorado and GLP-1s in 2026

No – as of June 2026, Health First Colorado does not cover Wegovy, Zepbound, or Saxenda when prescribed only for weight loss, though it does cover GLP-1s such as Ozempic and Mounjaro for type 2 diabetes with prior authorization. Health First Colorado is the official name of Colorado’s Medicaid program, and like most state Medicaid programs it treats GLP-1 coverage as an indication question: the same class of medication can be covered for type 2 diabetes and excluded when the prescription is written only for weight loss. According to a January 2026 KFF analysis, only 13 state fee-for-service Medicaid programs covered GLP-1s for obesity treatment, and Colorado was not among them. Reporting from GoodRx and NPR describes the same national pattern: most state Medicaid programs limit GLP-1 access for weight loss because of cost. This guide breaks down what Health First Colorado covers drug by drug, the Colorado-specific changes worth watching in 2026-2027, and your realistic options if coverage is denied. For the national picture, see our Medicaid GLP-1 coverage by state guide.

Important – verify your specific plan

Coverage details can change during the year, and individual circumstances matter. Before making any treatment decision, confirm current coverage directly: the Health First Colorado pharmacy line is 888-672-7203, and the program publishes its pharmacy rules through the Colorado Department of Health Care Policy & Financing (HCPF) at hcpf.colorado.gov/pharmacy-benefits. If you are enrolled through a managed care arrangement, ask your specific plan how it administers the pharmacy benefit, because handling can vary by plan. Your prescriber’s office can also check the current Preferred Drug List (PDL) status of any GLP-1 before submitting a prescription. Nothing in this guide is medical or legal advice – it is an educational summary of publicly available coverage information as of June 2026.

Health First Colorado GLP-1 coverage at a glance

Here is how the major GLP-1 medications stand with Health First Colorado as of June 2026. Coverage for diabetes-indicated agents is subject to the Preferred Drug List, and non-preferred agents require prior authorization.

Drug	FDA-approved indication	Health First Colorado coverage (June 2026)	Prior authorization?
Ozempic (semaglutide)	Type 2 diabetes	Covered, subject to the PDL	Required if non-preferred
Wegovy (semaglutide)	Chronic weight management	Not covered for weight loss	N/A – excluded for weight loss
Zepbound (tirzepatide)	Chronic weight management; obstructive sleep apnea	Not covered for weight loss	Ask your provider about indication-based PA
Mounjaro (tirzepatide)	Type 2 diabetes	Covered, subject to the PDL	Required if non-preferred
Saxenda (liraglutide)	Chronic weight management	Not covered for weight loss	N/A – excluded for weight loss
Trulicity (dulaglutide)	Type 2 diabetes	Covered, subject to the PDL	Required if non-preferred

Ozempic on Health First Colorado (2026)

Health First Colorado covers Ozempic for type 2 diabetes as of June 2026, subject to the program’s Preferred Drug List. Ozempic’s FDA-approved indication is type 2 diabetes, not weight management, so the prescription must be tied to a diabetes diagnosis. Whether Ozempic is a preferred or non-preferred agent at any given time is set on the PDL, which is published through HCPF’s pharmacy benefits page – if it is non-preferred when your prescription is written, your provider will need to submit a prior authorization request. Asking a prescriber to write Ozempic off-label purely for weight loss is unlikely to clear Medicaid coverage rules and is not something this guide recommends pursuing.

Wegovy on Health First Colorado (2026)

Health First Colorado does not cover Wegovy for weight loss as of June 2026. Wegovy is FDA-approved for chronic weight management, and weight-loss-only GLP-1 prescriptions fall outside the program’s covered pharmacy benefit, per GoodRx’s state-by-state Medicaid tracking and KFF’s January 2026 coverage analysis. This is a state policy position rather than a permanent rule – states can and do change course, and the section on what to watch in 2026-2027 below covers the live legislative and federal pathways. For now, Colorado members seeking Wegovy specifically for weight loss will generally need to look at cash-pay options, covered in the alternatives section below.

Zepbound on Health First Colorado (2026)

Health First Colorado does not cover Zepbound for weight loss as of June 2026. Zepbound is FDA-approved for chronic weight management, and like Wegovy and Saxenda it is excluded when prescribed solely for that purpose. One nuance worth knowing: Zepbound also carries a separate FDA indication for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, and OSA is a distinct clinical indication from weight management. If you have a documented OSA diagnosis, ask your provider whether an indication-based prior authorization request is appropriate in your case. We cannot say how Health First Colorado would decide such a request – this guide makes no claim about OSA-based approval outcomes – but it is a conversation worth having with your prescriber rather than assuming a denial in advance.

Mounjaro on Health First Colorado (2026)

Health First Colorado covers Mounjaro for type 2 diabetes as of June 2026, subject to the Preferred Drug List. Mounjaro contains the same active ingredient as Zepbound (tirzepatide) but carries the diabetes indication, which is why the two products sit on opposite sides of the coverage line. As with Ozempic, the PDL determines whether Mounjaro is preferred at the time of prescribing; non-preferred status triggers a prior authorization requirement, which your provider handles. Members with type 2 diabetes who are denied one GLP-1 agent should ask their prescriber about preferred alternatives on the current PDL rather than abandoning the class.

Don’t confuse Health First Colorado with Colorado’s state-employee plan changes

A lot of Colorado GLP-1 search traffic mixes up two entirely different programs, so let’s separate them clearly. Health First Colorado is the state’s Medicaid program for income-eligible residents. Colorado’s state-employee health plans are the benefits packages offered to people who work for the state government. They are run by different agencies under different rules. The widely reported 2025 change applied to the state-employee plans: effective July 1, 2025, Colorado removed GLP-1 weight-loss coverage for state employees, with a grandfathering arrangement under which existing users saw their copay rise from $30 to $120, according to the state’s GLP-1 FAQ for employees and reporting from The Colorado Sun. If you read a headline about Colorado “cutting GLP-1 coverage,” it was about the employee plans – it did not change Health First Colorado’s position, which already excluded weight-loss-only GLP-1s.

What if you can’t get a GLP-1 through Health First Colorado?

If your goal is weight loss and Health First Colorado will not cover the medication, you have a few realistic paths as of June 2026. First, if you have type 2 diabetes, work with your prescriber on a covered diabetes-indicated GLP-1 through the PDL process described below. Second, check manufacturer savings and patient-assistance programs, though Medicaid enrollees are often excluded from copay cards – read the fine print carefully. Third, consider cash-pay telehealth programs, which have become the most common route for people whose insurance excludes weight-loss GLP-1s; our guide to getting a GLP-1 without insurance in 2026 walks through realistic monthly costs. Colorado residents can also review local treatment context in our Colorado GLP-1 weight-loss guide.

GLP-1 alternatives for Colorado residents in 2026

If Health First Colorado won’t cover your weight-loss GLP-1, the most common pivot is to a cash-pay telehealth program offering compounded semaglutide or tirzepatide. These programs do not bill Medicaid – you pay out of pocket – but entry pricing is far below the retail cost of branded pens, and both options below prescribe in Colorado.

Ro Body Program

Telehealth weight-loss program with branded GLP-1 access (when in stock) and a coaching layer. Strong clinical workflow; one of the most established players. For Colorado members coming off a Medicaid denial, Ro’s structured intake and provider follow-up make it a reasonable first stop. See Ro Body Program pricing.

Remedy Meds

Compounded-GLP-1 focused telehealth with transparent pricing. Frequently lower entry price than Ro’s branded program. If monthly budget is the deciding factor – which it usually is after a Medicaid denial – Remedy Meds is worth comparing first. See Remedy Meds pricing.

Trim Rx

Cash-pay compounded telehealth with flat published pricing – oral semaglutide from $179/month and tirzepatide at $349/month flat at every dose, as of June 2026. It is a young company (founded 2024) with mixed customer-service reviews, so read our Trim Rx review for the complaint patterns and cancellation terms before enrolling.

You can compare these and other vetted programs side by side on our GLP-1 telehealth comparison page.

How prior authorization works for diabetes GLP-1s

For covered diabetes indications, Health First Colorado’s prior authorization process is faster than many members expect. Here is the typical flow as of June 2026. Your prescriber documents your type 2 diabetes diagnosis and selects an agent; if that agent is non-preferred on the current Preferred Drug List, the prescriber submits a prior authorization request with the supporting clinical information the PDL criteria call for. According to the Health First Colorado pharmacy benefits FAQ, prior authorization requests are processed in up to 24 hours. The specific clinical criteria for each agent live on the PDL itself, published through HCPF’s pharmacy benefits page, so your provider should check the current version rather than relying on last year’s rules. If you hit a snag at the pharmacy counter, the member pharmacy line at 888-672-7203 can tell you whether a PA is pending, approved, or denied.

Could Colorado add coverage? What to watch in 2026-2027

Colorado’s exclusion of weight-loss GLP-1s is a policy choice under active pressure, and three developments are worth tracking.

The 2024 legislative attempt failed on cost. A 2024 Colorado bill that would have required both Medicaid and private insurers to cover GLP-1s for weight loss died in the House Appropriations Committee, with first-year costs estimated at roughly $86 million, as reported by CBS Colorado. The fiscal math that killed that bill has not changed dramatically, which tempers expectations for a near-term Medicaid mandate.

SB25-048 changes private insurance, not Medicaid. SB25-048, signed June 3, 2025, requires Colorado large-group private health plans, starting January 1, 2027, to cover obesity treatment – including the Diabetes Prevention Program, medical nutrition therapy, behavioral support, and bariatric surgery – and to offer an optional rider covering anti-obesity medications, including at least one GLP-1. The American Diabetes Association welcomed the signing. To be explicit: this law applies to private large-group insurance and does not add GLP-1 weight-loss coverage to Health First Colorado.

The federal BALANCE Model is the live Medicaid pathway. CMS’s BALANCE Model lets states opt in to discounted GLP-1 pricing for obesity coverage in Medicaid, with rollout running May 1, 2026 through January 1, 2027 and a state application deadline of July 31, 2026, per KFF’s explainer. Colorado had not announced participation as of June 2026 – the July 31 deadline makes this the single most important date to watch. Separately, for Medicare beneficiaries, the federal GLP-1 Bridge program offers a $50 monthly copay for select Wegovy and Zepbound prescriptions from July 1, 2026 through December 31, 2027, per CMS; see our Medicare weight-loss medication guide for details.

Frequently asked questions

Does Health First Colorado cover Wegovy for weight loss?

No. Health First Colorado does not cover Wegovy for weight loss as of June 2026. Per KFF’s January 2026 analysis, Colorado is not among the 13 state fee-for-service Medicaid programs that cover GLP-1s for obesity treatment.

Does Colorado Medicaid cover Ozempic?

Yes, for type 2 diabetes. Health First Colorado covers Ozempic for its FDA-approved diabetes indication as of June 2026, subject to the Preferred Drug List, with prior authorization required for non-preferred agents. It is not covered for weight loss in members without diabetes.

Does Health First Colorado cover Zepbound?

Not for weight loss. Health First Colorado does not cover Zepbound when prescribed only for weight management as of June 2026. Because Zepbound carries a separate FDA indication for obstructive sleep apnea, members with diagnosed OSA should ask their provider whether an indication-based prior authorization request is worth pursuing; approval is not guaranteed.

How do I get a GLP-1 covered for type 2 diabetes in Colorado?

Work with your prescriber, who checks the current Preferred Drug List and submits prior authorization if the chosen agent is non-preferred. Health First Colorado states that PA requests are processed in up to 24 hours, and the member pharmacy line at 888-672-7203 can check the status of a request.

Will Colorado Medicaid start covering weight-loss drugs?

Not announced as of June 2026. A 2024 bill mandating coverage died in committee over an estimated $86 million first-year cost, and SB25-048’s 2027 obesity-coverage rules apply to large-group private plans, not Medicaid. The realistic pathway is the CMS BALANCE Model, which Colorado had not opted into as of June 2026; the state application deadline is July 31, 2026.

What are my options if Health First Colorado won’t cover a GLP-1?

If you have type 2 diabetes, pursue a covered diabetes-indicated GLP-1 through the PDL process. If your goal is weight loss only, cash-pay telehealth programs such as Ro Body Program and Remedy Meds are the most common route, with compounded options typically priced well below branded retail. Compare current pricing on our weight-loss comparison page before committing.

Does Health First Colorado Cover GLP-1 Weight Loss Drugs in 2026?